Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)

What is the purpose of this trial?

Multi-center, global, prospective, randomized, interventional, pre-market trial with two subject groups: the randomized group will be randomized on 1:1 basis to either the study device or to conventional mitral valve surgery. Subjects in the single-arm group will receive the study device.

Subjects will be seen at pre- and post-procedure, discharge, 30 days, 6 months, and annually through 5 years.

Participation Guidelines

Ages: 18 years and older

Gender: Both

Medtronic, Inc

Start Date: 03/05/2018

End Date: 10/31/2021

Last Updated: 01/17/2019

Study HIC#: 2000021883

Get Involved

For more information about this study, contact:
Sarah McManus
+1 203-737-1868

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


John Forrest

Principal Investigator